Amgen Inc. (AMGN)
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
Let's look at five biotech and drug companies, AMGN, GILD, LLY, VTRS & NVO, due to release their second-quarter 2024 results this week.
3 Biotech Stocks That Could Have Investors Grinning Soon
Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their investigational therapies fail to make it to market.
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
Amgen is developing a promising anti-obesity candidate. This product could be a blockbuster by 2030.
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
Amgen (AMGN) closed at $335.53 in the latest trading session, marking a +0.92% move from the prior day.
Exploring Analyst Estimates for Amgen (AMGN) Q2 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
The Top 3 Biotech Stocks to Buy Now Summer 2024
In the bustling world of biotechnology, innovation remains the cornerstone of growth. Some biotech stocks, known for their groundbreaking research and rapid adaptation to health challenges, are particularly well-positioned to do well in the future.
Can Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings?
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen (AMGN) Advances But Underperforms Market: Key Facts
In the closing of the recent trading day, Amgen (AMGN) stood at $334.85, denoting a +0.16% change from the preceding trading day.
3 Fabulous Growth Stocks to Buy and Hold Forever
Investors have been on a roller coaster ride for the past four years. One of the longest bull markets in history was brought to a screeching halt by the global pandemic.
7 Biotech Stocks to Keep on Your Clinical Radar
Initially, I had every intention to write a cookie-cutter assessment of intriguing biotech stocks; that is, I wanted to say that enterprises within this specialized healthcare field will always be relevant as humans leverage advanced innovations to address vexing conditions and diseases. That remains true.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
